Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
market access
Marketing
Fingerpaint buys MYND for market access skills, vaccine pedigree
By acquiring MYND Group, Fingerpaint has continued its takeover spree and added to the capabilities of its recently rebranded market access group.
Nick Paul Taylor
Apr 5, 2023 7:55am
'Startup like no other': Hengrui goes global with new unit
May 18, 2022 7:00am
GSK, Novartis lead pharma at making their meds accessible
Jan 26, 2021 12:12pm
Moderna hitches a ride with Uber to speed up COVID vaccine info
Jan 14, 2021 10:00am
AZ's Lynparza gets NICE nod for BRCA-positive ovarian cancer
Jul 26, 2019 10:41am
Allergan's new concierge platform books aesthetics treatments
Apr 18, 2019 10:13am
